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Abstract We have previously demonstrated that calcineurin and
p38 mitogen-activated protein kinase (MAPK) are up-regulated
in the hearts of mdx mice. However, the degree of up-regulation
observed was variable, which may reflect variable levels of daily
physical activities among the mice. To investigate whether or
not exercise affects dystrophic features and activates intracel-
lular signaling molecules in mdx hearts, we subjected mdx and
C57BL/10 mice to treadmill exercise and examined intracellular
signaling molecules in cardiac muscles, at the protein level. The
heart to body weight ratio was significantly increased in
exercised mdx mice. Histopathology in exercised mdx hearts
showed extensive infiltration of inflammatory cells, together
with increases in interstitial fibrosis and adipose tissues, all of
which were not observed either in exercised C57BL/10 or non-
exercised mdx hearts. Phosphorylated p38 MAPK, phosphory-
lated extracellular signal-regulated kinase 1/2 and calcineurin,
but not phosphorylated c-Jun N-terminal kinase 1, were up-
regulated in exercised mdx hearts compared to exercised
C57BL/10 or non-exercised mdx hearts. These data suggest
that physical exercise accelerates the dystrophic process through
activation of intracellular signaling molecules in dystrophin-
deficient hearts. 2 2002 Federation of European Biochemical
Societies. Published by Elsevier Science B.V. All rights re-
served.
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1. Introduction
Duchenne and Becker muscular dystrophies (DMD/BMD)
are X-linked recessive diseases characterized by progressive
muscle wasting, and both diseases are caused by mutations
in the DMD gene. In DMD and BMD patients, congestive
heart failure with cardiomyopathy is one of the main causes
of death. Dilated cardiomyopathy is the most common type of
cardiomyopathy, and in some patients it is preceded by hyper-
trophic cardiomyopathy [1]. BMD patients who are mildly
a¡ected, or are in the subclinical stage, often show severe
cardiomyopathy [2]. It has been hypothesized that the slow
progression of muscular weakness permits a prolonged work-
load on an impaired myocardium in these BMD patients,
eventually resulting in cardiomyopathy [1,2]. However, the
hypothesis has not been con¢rmed.
Dystrophin, the DMD gene product, is a structural mem-
brane protein, which maintains the mechanical stability of the
muscle ¢ber membrane during muscle contraction and relax-
ation, and regulates intracellular calcium homeostasis, possi-
bly by modulation of muscle-speci¢c ion channels [3]. Some
reports document that dystrophin-de¢cient skeletal and car-
diac muscles can be more easily damaged than normal
muscles by mechanical stresses such as physical exercise [4^
7]. Physical exercise or injury is a powerful stimulator of mi-
togen-activated protein kinase (MAPK) cascades in human
skeletal muscle. The c-Jun N-terminal kinases (JNKs), p38
MAPK and extracellular signal-regulated kinase 1 and 2
(ERK1/2) are major components of this cascade [8,9]. Calci-
neurin, a calcium dependent protein phosphatase, is another
intracellular signaling molecule induced by mechanical stress,
leading to cardiac and skeletal muscle hypertrophy [10^12]. In
fact, we have previously reported that JNK1, p38 MAPK and
calcineurin were involved in the pathogenesis of dystrophin
de¢ciency in cardiac muscle [13]. Taken overall, we speculated
that physical exercise might directly a¡ect dystrophic features
in mdx hearts and activate p38 MAPK, JNK1, ERK1/2 or
calcineurin signaling in cardiac muscle. To test this hypothe-
sis, we subjected mdx and C57BL/10 mice to physical exercise.
Here, we show that progression of dystrophic features and
signi¢cant activation of p38 MAPK, ERK1/2 and calcineurin,
but not JNK1, are observed in exercised mdx hearts compared
to those in both exercised C57BL/10 and non-exercised mdx
hearts.
2. Materials and methods
2.1. Animals and treadmill exercise
Six-week-old male dystrophin-de¢cient (mdx) and control (C57BL/
10) mice were used in this study. Animals were exercised using a
treadmill manufactured by Takaramachi Kikai Company (Japan)
that had an adjustable belt speed (0^70 m/min), shock bars with ad-
justable belt amperage (0^1 mA), and an on^o¡ shock switch for each
lane. A total of 24 mice were separated into four groups: non-exer-
cised C57BL/10 (n=6), exercised C57BL/10 (n=6), non-exercised mdx
(n=6) and exercised mdx (n=6). In the exercised group, the treadmill
exercise protocol basically followed that described in the previous
report [14]; the mice were placed on the treadmill and run with up-
stairs inclination of 7‡, at 15 m/min for 60 min, twice per week for
5 weeks. Thereafter the speed was increased to 23 m/min (same incli-
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nation) and the exercise continued for another 5 weeks. In the non-
exercised group, the mice were placed in the treadmill at 2 m/min and
0‡ incline for the same period as the exercised group. All the mice
were completed each exercise without rest and ¢nished a 10-week
protocol. Thus, they were exercised for the same total time. The
body weight of each mouse was measured every week. After the pro-
tocol, mice were anesthetized with diethylether and sacri¢ced. The
hearts were excised, rinsed in saline and weighed. The heart to body
weight ratio was calculated. Heart muscle samples were frozen in
cooled isopentane, and stored at 380‡C until analyzed. This study
was carried out in accordance with the Guide for Animal Experimen-
tation, Institute of Experimental Animals, Shinshu University School
of Medicine, and all procedures were approved by the Institute Ani-
mal Care and Use Committee.
2.2. Microscopic analyses
Transverse cryostat sections (8-Wm thickness) of left ventricular
myocardium were prepared and stained with hematoxylin and eosin
(HpE). To judge the extent of the myocardial damage, the percentage
of the areas of dystrophic lesion to the total of the left ventricular was
determined using MacSCOPE (Mitani Corporation, Japan).
2.3. Western blot analyses
The heart tissues were homogenized in a gel-loading bu¡er (62.5
mM Tris^HCl pH 6.8, 2% SDS, 10% glycerol) and the total protein
content was assessed (Bio-Rad DC Assay kit). After the addition of
L-mercaptoethanol (¢nal concentration: 5%), 100 Wg of each extract
was separated on an 8% or 10% SDS^polyacrylamide gel and electro-
blotted onto a PDEF membrane Immobilon1 (Millipore). The blot
was blocked in Tris-bu¡ered saline with 0.1% Tween 20 (TBST) con-
taining 5% skimmed milk (w/v). Antibodies used for the primary in-
cubation were: anti-GAPDH and anti-calcineurin (MAB374 and
MAB1694, respectively, Chemicon International, Inc.), anti-phos-
phorylated (p-)p38 MAPK, activated form of p38 MAPK (#9211S,
New England Biolabs), anti-phosphorylated JNK1, activated form of
JNK1 (SC6254, Santa Cruz Biotechnology, Inc.), and anti-phosphor-
ylated ERK1/2, activated form of ERK1/2 (#9252, New England Bio-
labs). All membranes were incubated with primary antibodies at 4‡C
overnight. After labeling, the membranes were washed three times in
TBST for 10 min each and then incubated with appropriate species-
speci¢c horseradish peroxidase-conjugated secondary antibodies for
enhanced chemiluminescence (ECL Plus Western blotting detection
kit, Amersham Pharmacia Biotech).
2.4. Immunohistochemistry
7-Wm sections of frozen tissue were collected on coated slides and
allowed to air dry. The slides were washed twice in phosphate-bu¡-
ered saline (PBS). All polyclonal antibodies against p-p38 MAPK,
p-ERK1/2, calcineurin, and GAPDH were diluted 1:500 in PBS
with 5% goat serum and applied directly to the sections. The slides
were incubated overnight at 4‡C in a humidi¢ed box, then washed
three times with PBS for 10 min. The labeled secondary antibody
(anti-rabbit IgG for p-p38 MAPK, p-ERK1/2 and calcineurin, and
anti-mouse IgG for GAPDH, £uorescein isothiocyanate (FITC) (San-
ta Cruz) or biotin-labeled (Dako)), at 1:100 dilutions in PBS with 5%
goat serum, was applied and slides incubated for a further 1 h. After
washing the slides with PBS three times, the FITC-labeled sections
were mounted using glycerol-mounting medium, or the biotin bound
antibodies were visualized by avidin^biotin peroxidase kits (Vectas-
tain, Vector Laboratories) using diaminobenzidine (Dako) and the
sections were counterstained with hematoxylin.
2.5. Statistical analyses
Semi-quantitative assessment of band intensity was performed by
using the NIH Image software package, and the level of each protein
relative to that of GAPDH was calculated. The unpaired Student’s
t-test was performed to compare two groups (non-exercised C57BL/10
vs exercised C57BL/10, non-exercised C57BL/10 vs non-exercised
mdx, exercised C57BL/10 vs exercised mdx, and non-exercised mdx
vs exercised mdx). A P value 6 0.05 was considered statistically sig-
ni¢cant. All values are expressed as meanUS.E.M.
3. Results
3.1. Body weight during the treadmill exercise and heart to
body weight ratio
We found no signi¢cant di¡erence in body weight between
non-exercised C57BL/10 and exercised C57BL/10 mice; how-
ever, the weight of exercised C57BL/10 mice was slightly heav-
ier than that of non-exercised C57BL/10 at each time point
(Fig. 1A). Furthermore, the body weight of exercised mdx
mice was slightly less (but not signi¢cantly) than that of
non-exercised mdx (Fig. 1B). The di¡erence in ¢nal body
Fig. 1. Timetable showing body weight changes in C57BL/10 and
mdx mice in exercised or non-exercised groups (n=6 for each
group). Bar shows mean+S.E.M.
Table 1
Percentage of area of dystrophic lesion to left ventricle
Percentage of area (meanUS.E.M.)
C57BL/10
Non-exercised (n=6) 0.05U 0.02%
Exercised (n=6) 0.06U 0.04%
mdx
Non-exercised (n=6) 1.68U 0.31%*
Exercised (n=6) 6.23U 0.70%**;***
*P6 0.01, non-exercised C57BL/10 vs non-exercised mdx.
**P6 0.01, non-exercised mdx vs exercised mdx.
***P6 0.01, exercised C57BL/10 vs exercised mdx.
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weight between the groups was not statistically signi¢cant
(Fig. 2A). The heart weight of each exercised group was
slightly greater than that of each non-exercised group, but
the di¡erences were also not statistically signi¢cant (data
not shown). However, the ratio of heart to body weight in
exercised mdx mice was slightly but signi¢cantly higher than
that in non-exercised mdx or exercised C57BL/10 (Fig. 2B).
3.2. Histopathology of heart
We examined the left ventricular myocardium histopatho-
logically. Macroscopically, the hearts in exercised mdx mice
seemed to be slightly larger than those in non-exercised mdx ;
however, dilatation of left ventricle and thickness or thinness
of left ventricular wall were not evident (data not shown).
HpE staining of the samples showed no remarkable change
in either non-exercised or exercised C57BL/10 mice (Fig.
3A,B), while in mdx mice, non-exercised cardiac muscle
showed a slightly dystrophic change such as ¢ber necrosis
and atrophy, together with slight in¢ltration of in£ammatory
cells (Fig. 3C). In exercised mdx cardiac muscle, the amount
of interstitial ¢brosis and adipose tissue was increased; in¢l-
tration of in£ammatory cells was prominently enhanced and
¢ber disorganization was observed (Fig. 3D). We semi-quan-
titatively evaluated the lesion of ¢brosis, adipose tissue and
in¢ltration of in£ammatory cells in the myocardium of the left
ventricle. The di¡erence of the percentage of dystrophic lesion
in the myocardium between non-exercised and exercised
C57BL/10 was not signi¢cant. While the percentage in non-
exercised and exercised mdx groups was much higher than
that in C57BL/10 groups. When compared between non-exer-
cised and exercised mdx hearts, the percentage was more
greatly increased in exercised mdx (Table 1).
3.3. Up-regulation of p-p38 MAPK, p-ERK1/2 and calcineurin
in the hearts
We next examined levels of the activated forms of p38
MAPK (p-p38 MAPK), JNK1 (p-JNK1) and ERK1/2 (p-
ERK1/2), and calcineurin in cardiac muscles by Western blot-
ting. p-p38 MAPK was increased two-fold in exercised
C57BL/10 hearts compared to non-exercised C57BL/10 hearts
(Figs. 4 and 5), while the level in non-exercised mdx hearts
was elevated three-fold, compared to non-exercised C57BL/10
hearts. These data were consistent with our previous report
[13]. Moreover, p-p38 MAPK levels displayed a more dramat-
ic increase in exercised mdx hearts than in exercised C57BL/10
or non-exercised mdx hearts. However, the level of p-JNK1
was not always up-regulated by exercise (Figs. 4 and 5). The
relative level of p-ERK1/2 and calcineurin to GAPDH
showed a similar pro¢le. The basal level of these proteins
was up-regulated in mdx hearts compared to C57BL/10
hearts, and physical exercise increased the level of these pro-
teins, especially in mdx mice (Figs. 4 and 5).
We also investigated the localization of p-p38 MAPK,
p-ERK1/2 and calcineurin by immunohistochemistry. Immu-
noreactivities with antibodies against p-p38 MAPK, p-ERK1/
2 and calcineurin were increased in degenerative ¢bers around
the ¢brotic change or the in¢ltration of in£ammatory cells in
non-exercised and exercised mdx hearts (Figs. 6 and 7). And
the signals seemed to be stronger in the exercised groups than
non-exercised groups.
4. Discussion
We have shown that the heart to body weight ratio of
exercised mdx mice was signi¢cantly increased; this might
partly re£ect the fact that the body weight was slightly less
in exercised mdx mice than in non-exercised mdx. But com-
pared to non-exercised mdx mice, the heart weight itself was
increased in exercised mdx. It has recently been reported that
the heart to body weight ratio of mdx mice was 45% higher at
6 months of age, and that mdx heart showed hypertrophic
changes by this age [15]. More importantly, we are the ¢rst
to have demonstrated that physical exercise induces dystro-
phic features in cardiac muscle of mdx mice. As for the in-
volvement of cardiac muscle in the changes observed in mdx
Fig. 2. A: Final body weight of C57BL/10 and mdx mice in exer-
cised or non-exercised groups (n=6 for each group). Bar shows
mean+S.E.M. B: Heart to body weight ratio of C57BL/10 and mdx
mice in exercised or non-exercised groups (n=6 for each group).
Bar shows mean+S.E.M.
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mice, previously reported ¢ndings have been controversial :
some papers reported extensive necrosis and ¢brosis in mdx
cardiac muscle [16,17], while others indicated the absence of a
pathologic lesion [18,19]. The di¡erence observed was consid-
ered to be associated with the physical activity of the mice
[20], and our data support this hypothesis.
In the next step, we focused on some stress-activated pro-
tein kinases and calcineurin as key molecules mediating exer-
cise-induced cardiac involvement. MAPKs constitute a con-
served family of serine/threonine protein kinases that regulate
many cellular responses, including cell proliferation, di¡eren-
tiation and survival [21]. Activation of MAPK signaling also
mediates changes in expression of muscle genes in response to
exercise or injury [8,9]. Calcineurin is a protein phosphatase
that is activated by a sustained increase in intracellular free
calcium concentration, and which can be induced by mechan-
ical stress [10]. Since dystrophin-de¢cient muscle membranes
are vulnerable to mechanical stress [4^7], and since mechan-
ical stress is a powerful stimulator of stress-activated protein
kinases and of calcium in£ux, we hypothesized that MAPKs
and calcineurin may be strongly activated in dystrophin-de¢-
cient cardiac muscle by physical exercise. We also hypothe-
sized that up-regulation of these signaling pathways may
modulate the dystrophic process. As expected, the results
from the Western blots showed that p-p38 MAPK,
p-ERK1/2 and calcineurin registered a signi¢cant increase in
exercised mdx hearts compared to the exercised C57BL/10 or
non-exercised mdx hearts. Moreover, the immunohistochemi-
cal studies showed that the immunoreactivities of p38 MAPK,
ERK1/2 and calcineurin were strong, especially in the degen-
erative ¢bers around or in the dystrophic lesion in mdx hearts.
Fig. 3. HpE staining of left ventricular myocardium of exercised or non-exercised C57BL/10 and mdx mice (U100).
Fig. 4. Representative Western blotting analyses of p-p38 MAPK,
p-JNK1, p-ERK1/2, calcineurin and GAPDH in left ventricular my-
ocardium of exercised or non-exercised C57BL/10 and mdx mice
(n=6 for each group).
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In contrast to p-p38 MAPK, p-ERK1/2 and calcineurin,
p-JNK1 was slightly down-regulated by exercise in mdx car-
diac muscles. At present, we do not have satisfactory expla-
nation for this, however, this is partially consistent with our
previous report [13]. Together with the reports that p-JNK1
was increased in 5-month-old mdx hearts [22] and that acti-
vation of multiple cardiac MAPK pathways largely depends
on the stages of cardiac damage [23], the regulation of p-
JNK1 may depend on the developmental stage of cardiomy-
opathy in mdx. Further study will be needed to see how JNK1
is regulated in the development of dystrophic change in heart.
These MAPK molecules or calcineurin might presumably
be involved in the dystrophic feature, thus we here discuss
how the activation of these molecules modulates progression
of the dystrophic process. MAPKs and calcineurin are
thought to share two main roles. Firstly, these signaling mol-
Fig. 5. Relative (to GAPDH) protein levels of p-JNK1, p-p38 MAPK, p-ERK1/2, calcineurin in C57BL/10 and mdx in left ventricular myocar-
dium of exercised or non-exercised groups (n=6 for each group). Bar: mean+S.E.M.; ns: not signi¢cant; *P6 0.05; **P6 0.01.
Fig. 6. Immunohistochemistry of cardiac muscle in exercised or non-exercised C57BL/10 and mdx mice (U100).
FEBS 26095 27-5-02 Cyaan Magenta Geel Zwart
A. Nakamura et al./FEBS Letters 520 (2002) 18^2422
ecules may be involved in the process of muscle ¢brosis and/or
regeneration. Several growth factors, for example transform-
ing growth factor-L, basic ¢broblast growth factor, platelet-
derived growth factor and insulin-like growth factor, may be
important players in the process of ¢brotic proliferation and
muscle regeneration [24]; in addition calcineurin and MAPK
are involved in activation of these growth factors [25^27].
Furthermore, considering the fact that muscle-speci¢c en-
hancer factor MEF2 activity is increased in regenerating skel-
etal muscle [28] and that both calcineurin and MAPKs (espe-
cially p38 MAPK) can activate MEF2 DNA binding activity
[29,30], the process of muscle ¢brosis and regeneration in
dystrophin-de¢cient muscle may be in£uenced by calcineurin
and MAPKs.
Secondly, MAPKs and calcineurin may be associated with
apoptosis in dystrophin-de¢cient muscle. A study of muscle
biopsies from DMD patients con¢rmed the presence of apo-
ptosis, together with an up-regulation of the pro-apoptotic
gene bax and a down-regulation of the anti-apoptotic gene
bcl-2 [31]. In mdx mice, apoptotic nuclei were seen only in
degenerating muscle ¢bers [32] ; apoptotic nuclei in the ¢bers
were increased in number and expression of the bcl-2 gene was
down-regulated in exercising mdx muscles [33]. Calcineurin
induces apoptosis through dephosphorylation of Bad, which
is a pro-apoptotic member of the Bcl-2 family [34], and
MAPKs are also directly involved in regulation of the apo-
ptotic cascade [35]. Therefore, both pathways could take part
in apoptosis in dystrophin-de¢cient muscle.
We have previously reported that calcineurin, JNK1 and
p38 MAPK signaling pathways are up-regulated in cardiac
muscle of utrophin^dystrophin-de¢cient mice, and that calci-
neurin and p38 MAPK are also up-regulated in mdx hearts
[13]. In the present study, we showed that physical exercise
accelerated dystrophic features and that p38 MAPK, ERK1/2
and calcineurin were signi¢cantly activated in the exercised
mdx hearts. In the future, it will be necessary to clarify in
more detail how the up-regulation of these signaling molecules
is associated with the progression of dystrophic features in the
heart. For this purpose, it is informative to see the e¡ects of
the inhibitors of MAPKs [36^38] or calcineurin on mdx
hearts. Based on our present data, we are now planning a
further trial of the inhibitors of p38 MAPK, ERK or calci-
neurin on exercised mdx mice in order to better understand
the mechanism of progression of the dystrophic change in
heart.
Acknowledgements: This work was supported by Research Grant
(11B-1) for Nervous and Mental Disorders from the Ministry of
Health, Labor and Welfare, Japan.
References
[1] Cox, G.F. and Kunkel, L.M. (1997) Curr. Opin. Cardiol. 12,
329^343.
[2] Melacini, P., Fanin, M., Danieli, G.A., Villanova, C., Martinello,
F., Miorin, M., Freda, M.P., Miorelli, M., Mostacciuolo, M.L.,
Fasoli, G., Angelini, C. and Dalla Volta, S. (1996) Circulation
94, 3168^3175.
[3] Infante, J.P. and Huszagh, V.A. (1999) Mol. Cell. Biochem. 195,
155^167.
[4] Petrof, B.J., Shrager, J.B., Stedman, H.H., Kelly, A.M. and
Sweeney, H.L. (1993) Proc. Natl. Acad. Sci. USA 90, 3710^3714.
[5] Moens, P., Baatsen, P.H. and Marechal, G. (1993) J. Muscle Res.
Cell. Motil. 14, 446^451.
[6] Danialou, G., Comtois, A.S., Dudley, R., Karpati, G., Vincent,
G., Des Rosiers, C. and Petrof, B.J. (2001) FASEB J. 15, 1655^
1657.
[7] Kamogawa, Y., Biro, S., Maeda, M., Setoguchi, M., Hirakawa,
T., Yoshida, H. and Tei, C. (2001) Cardiovasc. Res. 50, 509^
515.
[8] Ryder, J.W., Fahlman, R., Wallberg-Henriksson, H., Alessi,
D.R., Krook, A. and Zierath, J.R. (2000) J. Biol. Chem. 275,
1457^1462.
[9] Aronson, D., Wojtaszewski, J.F.P., Thorell, A., Nygren, J., Zan-
gen, D., Richter, E.A., Ljungqvist, O., Fielding, R.A. and Good-
year, L.J. (1998) Am. J. Physiol. 275, C555^C561.
[10] Molkentin, J.D., Lu, J.R., Antos, C.L., Markham, B., Richard-
son, J., Robbins, J., Grant, S.R. and Olson, E.R. (1998) Cell 93,
215^228.
[11] Semsarian, C., Wu, M.-J., Ju, Y.-K., Marciniec, T., Yeoh, T.,
Allen, D.G., Harvey, R.P. and Graham, R.M. (1999) Nature 400,
576^581.
Fig. 7. P-p38 MAPK immunoreactivity of cardiac muscle ¢bers in exercised C57BL/10 and exercised mdx mice (U200). Diaminobenzidine sig-
nals were strong in the degenerative ¢bers around the ¢brosis (arrows) in exercised mdx heart (B) compared to those in exercised C57BL/10
heart (A).
FEBS 26095 27-5-02 Cyaan Magenta Geel Zwart
A. Nakamura et al./FEBS Letters 520 (2002) 18^24 23
[12] Musaro, A., McCullagh, K.J.A., Naya, F.J., Olson, E.N. and
Rosenthal, N. (1999) Nature 400, 581^585.
[13] Nakamura, A., Harrod, G.V. and Davies, K.E. (2001) Neuro-
musc. Disord. 11, 260^268.
[14] Fewell, J.G., Osinska, H., Klevitsky, R., Ng, W., Sfyris, G.,
Bahrehmand, F. and Robbins, J. (1997) Am. J. Physiol. 273,
H1595^H1605.
[15] Bia, B.L., Cassidy, P.J., Young, M.E., Rafael, J.A., Leighton, B.,
Davies, K.E., Radda, G.K. and Clark, K. (1999) J. Mol. Cell.
Cardiol. 31, 1857^1862.
[16] Bridges, L.R. (1986) J. Neurol. Sci. 72, 147^157.
[17] Sicinski, P. and Barnard, P.J. (1990) J. Neurol. Sci. S98, 122.
[18] Tanabe, Y., Esaki, K. and Nomura, T. (1986) Acta Neuropathol.
(Berlin) 69, 91^95.
[19] Torres, L.F.B. and Duchen, L.W. (1987) Brain 110, 269^299.
[20] Lefaucheur, J.P., Pastoret, C. and Sebille, A. (1995) J. Anat. Rec.
242, 70^76.
[21] Su, B. and Karin, M. (1996) Curr. Opin. Immunol. 8, 402^411.
[22] Megeney, L.A., Kablar, B., Perry, R.L.S., Ying, C., May, L. and
Rudnicki, M.A. (1999) Proc. Natl. Acad. Sci. USA 96, 220^
225.
[23] Hayashida, W., Kihara, Y., Yasaka, A., Inagaki, K., Iwanaga,
Y. and Sasayama, S. (2001) J. Mol. Cell. Cardiol. 33, 733^744.
[24] Gorospe, J.R.M., Nishikawa, B.K. and Ho¡man, E.P. (1997) in:
Dystrophin, Gene, Protein and Cell Biology, 1st edn. (Brown,
S.C. and Lucy, J.A., Eds.), pp. 201^232, Cambridge University
Press.
[25] Boilly, B., Vercoutter-Edouart, A.S., Hondermarck, H., Nur-
combe, V. and Le Bourshis, X. (2000) Cytokine Growth Factor
Rev. 11, 295^302.
[26] Ruwhof, C. and van der Laarse, A. (2000) Cardiovasc. Res. 47,
23^37.
[27] Tomono, M., Toyoshima, K., Ito, M. and Amano, H. (1996)
Biochem. J. 317, 675^680.
[28] Akkila, W.M., Chambers, R.L., Ornatsky, O.I. and McDermott,
J.C. (1997) Biochem. J. 325, 87^93.
[29] Olson, E.N. and Williams, R.S. (2000) Bioessays 22, 510^519.
[30] Zhao, M., New, L., Kravchenko, V.V., Kato, Y., Gram, H., di
Padova, F., Olson, E.N., Ulevitch, R.J. and Han, J. (1999) Mol.
Cell Biol. 19, 21^30.
[31] Sandri, M., Minetti, C., Pedemonte, M. and Carraro, U. (1998)
Lab. Invest. 78, 1005^1016.
[32] Matsuda, R., Nishikawa, A. and Tanaka, H. (1995) J. Biochem.
118, 959^964.
[33] Sandri, M., Podhorska-Okolow, M., Geromel, V., Rizzi, C.,
Arslan, P., Franceschi, C. and Carraro, U. (1997) J. Neuropa-
thol. Exp. Neurol. 56, 45^57.
[34] Wang, H.G., Pathan, N., Ethell, I.M., Krajewski, S., Yamaguchi,
Yu., Shibasaki, F., McKeon, F., Bobo, T., Franke, T.F. and
Reed, J.C. (1999) Science 284, 339^343.
[35] Cross, T.G., Scheel-Toellner, D., Henriquez, N.V., Deacon, E.,
Salmon, M. and Lord, J.M. (2000) Exp. Cell. Res. 256, 34^41.
[36] Lee, J.C. and Adams, J.L. (1995) Curr. Opin. Biotechnol. 6, 657^
661.
[37] Favata, M.F., Horiuchi, K.Y., Manos, E.J., Daulerio, A.J.,
Stradley, D.A., Feeser, W.S., Van Dyk, D.E., Pitts, W.J., Earl,
R.A., Hobbs, F., Copeland, R.A., Magolda, R.L., Scherle, P.A.
and Trzaskos, J.M. (1998) J. Biol. Chem. 273, 18623^18632.
[38] Whitmarsh, A.J., Cavanagh, J., Tournier, C., Yasuda, J. and
Davis, R.J. (1998) Science 281, 1671^1673.
FEBS 26095 27-5-02 Cyaan Magenta Geel Zwart
A. Nakamura et al./FEBS Letters 520 (2002) 18^2424
